Common Contracts
2 similar License Agreement contracts by Capstone Therapeutics Corp.
LICENSE AGREEMENT by and between ANJI PHARMACEUTICALS INC. and LIPIMETIX DEVELOPMENT, INC. MAY 2, 2018 LICENSE AGREEMENTLicense Agreement • May 5th, 2020 • Delaware
This License Agreement (the “Agreement”) is entered into as of May 2, 2018 (the “Effective Date”), by and between Anji Pharmaceuticals Inc., a company organized and existing under the laws of the Cayman Islands and having an address at P.O. Box 31119 Grand Pavilion, Hibiscus Way, 802 West Bay Road, Grand Cayman, KY1 – 1205, Cayman Islands (“Anji Pharma”) and LipimetiX Development, Inc. a corporation organized and existing under the laws of Delaware and having an address at 5 Commonwealth Road, Suite 2a, Natick, MA 01970 (“LipimetiX”). Anji Pharma and LipimetiX may each be referred to herein individually as a “Party” and collectively as the “Parties.”
LICENSE AGREEMENTLicense Agreement • May 7th, 2018 • Capstone Therapeutics Corp. • Pharmaceutical preparations • Delaware
This License Agreement (the “Agreement”) is entered into as of May 2, 2018 (the “Effective Date”), by and between Anji Pharmaceuticals Inc., a company organized and existing under the laws of the Cayman Islands and having an address at P.O. Box 31119 Grand Pavilion, Hibiscus Way, 802 West Bay Road, Grand Cayman, KY1 – 1205, Cayman Islands (“Anji Pharma”) and LipimetiX Development, Inc. a corporation organized and existing under the laws of Delaware and having an address at 5 Commonwealth Road, Suite 2a, Natick, MA 01970 (“LipimetiX”). Anji Pharma and LipimetiX may each be referred to herein individually as a “Party” and collectively as the “Parties.”
